Colin Hislop

2013 - Anthera Pharmaceuticals

In 2013, Colin Hislop earned a total compensation of $1M as Chief Medical Officer at Anthera Pharmaceuticals, a 89% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$28,665
Option Awards$601,998
Salary$350,000
Stock Awards$37,847
Total$1,018,510

Hislop received $602K in option awards, accounting for 59% of the total pay in 2013.

Hislop also received $28.7K in non-equity incentive plan, $350K in salary and $37.8K in stock awards.

Rankings

In 2013, Colin Hislop's compensation ranked 6,516th out of 12,286 executives tracked by ExecPay. In other words, Hislop earned more than 47.0% of executives.

ClassificationRankingPercentile
All
6,516
out of 12,286
47th
Division
Manufacturing
2,290
out of 4,612
50th
Major group
Chemicals And Allied Products
681
out of 1,462
53rd
Industry group
Drugs
496
out of 1,156
57th
Industry
Pharmaceutical Preparations
394
out of 890
56th
Source: SEC filing on April 9, 2015.

Hislop's colleagues

We found four more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2013.

2013

Paul Truex

Anthera Pharmaceuticals

Chief Executive Officer

2013

Debra Odink

Anthera Pharmaceuticals

Chief Technology Officer

2013

Christopher Lowe

Anthera Pharmaceuticals

Chief Financial Officer

2013

May Liu

Anthera Pharmaceuticals

Senior Vice President, Finance & Administration

In-depth

You may also like